These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6199705)

  • 1. Significance of serum tumor markers in patients with carcinoma of the ovary.
    Kikuchi Y; Kizawa I; Koyama E; Kato K
    Obstet Gynecol; 1984 Apr; 63(4):561-6. PubMed ID: 6199705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary].
    Kizawa I; Kikuchi Y; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):251-8. PubMed ID: 6833810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
    Kikuchi Y; Kita T; Iwano I; Kuki E; Oomori K; Kizawa I
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):69-76. PubMed ID: 2926196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactic dehydrogenase isozyme patterns and alpha-hydroxybutyrate dehydrogenase activities in serum from newborns, patients with ovarian cancer or myocardial infarction.
    Kikuchi Y; Kita T; Furuya K; Kato K
    Cancer Biochem Biophys; 1988 Nov; 10(2):125-9. PubMed ID: 3252958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production.
    Higuchi Y; Kouno T; Teshima H; Akizuki S; Kikuta M; Ohyumi M; Yamamoto S
    Arch Pathol Lab Med; 1984 Sep; 108(9):710-2. PubMed ID: 6205636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
    Tang BJ; Li L; Xu J
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):336-9, 381. PubMed ID: 8001406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer.
    Khoo SK; Daunter B; Mackay E
    Int J Gynaecol Obstet; 1979; 16(5):388-93. PubMed ID: 86469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma].
    Iwamoto I; Furukawa M; Ito S; Nakata T; Tanigawa M; Koga Y; Magari Y
    Gan No Rinsho; 1988 Feb; 34(2):208-12. PubMed ID: 2450213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of biochemical markers between benign and malignant ovarian cysts.
    Knight JA; Wu JT; Miya T; Knight DP
    Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the preoperative serum carcinoembryonic antigen level in early-stage adenocarcinoma of the uterine cervix.
    Tsai CC; Lin H; Huang EY; Huang SC; Hsieh CH; Chang SY; Chien CC
    Gynecol Oncol; 2004 Aug; 94(2):363-7. PubMed ID: 15297173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The present status of tumor markers in malignant ovarian tumor].
    Nishimura H; Miyoshi T; Hamai J; Miyahara K
    Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
    Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of an unusual isozyme of lactate dehydrogenase in the serum of cancer patients and comparison with carcinoembryonic antigen.
    Manly KF; Petrelli N; Anderson GR; Emrich LJ; Herrera L; Mittelman A
    Cancer Res; 1987 Nov; 47(22):6156-60. PubMed ID: 3664517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
    Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
    Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.